Delivery Order SPE2DB24D1205-SPE2DB25FCYVE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,366.88 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with an ultimate completion date of May 2, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 3, 2025, for 100 tablets of Onfil 10 mg with a ceiling value of $3,245.16. The delivery order employs firm fixed pricing with no set-aside designation, indicating the award was competitively achieved through open competition. The contract has an ultimate completion date of September 4, 2025, and performance will...
- The Defense Logistics Agency awarded a $3,086.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with an ultimate completion date of September 2, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems...
- The Defense Logistics Agency awarded a $2,652.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with an ultimate completion date of October 20, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle valued through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,638.32 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with performance in Conshohocken, Pennsylvania. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 26, 2025. The delivery order was awarded on August 25, 2025, and represents a single pharmaceutical transaction under AmerisourceBergen's broader federal contracting relationship. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Onfil 10 mg tablets (100 count) with a ceiling value of $3,064.78. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Onfil 10 mg tablets (100-count) under a firm fixed-price contract with a ceiling value of $7,471.73. This non-set-aside award is classified as a delivery order with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a specific pharmaceutical supply requirement within the...
- The Defense Logistics Agency awarded a delivery order valued at $7,345.58 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 20 mg on September 23, 2025, with completion scheduled for September 24, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Onfil 10 mg tablets (100-count units) with a ceiling value of $3,109.20. This firm fixed-price, non-set-aside contract is classified as a delivery order with an ultimate completion date of September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $7,517.04 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with a firm fixed price contract type. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and no set-aside designation was utilized. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a competitive procurement...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYVEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for 100 tablets of Onfil 10 mg, with a ceiling value of $1,979.06 and an ultimate completion date of July 24, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill a wide range of pharmaceutical and medical supply needs through competitive procurement processes. The SPE2DX IDC enables AmerisourceBergen to supply specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key provider within the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/23/25 |